Table 3.
Oxidative and inflammatory state in ovarian cancer. A significant increase of the 8-IP marker in ascites fluid versus baseline plasma levels can be observed. Also, an important leakage of antioxidants (TAC) in ascites fluid compared to plasma levels of healthy controls and the baseline TAC evaluations. A significant increase of IL-6 in ascites fluid versus baseline plasma levels was found. The TNF-α was significantly diminished in ascites and elevated in baseline evaluations.
Healthy control plasma | Ascites | Ŧ p = HC versus ascites | ¥ p = HC versus baseline | Plasma | ¤ p = baseline–final | § p = plasma baseline versus ascites | ||
---|---|---|---|---|---|---|---|---|
Basal | Final | |||||||
Oxidants | ||||||||
8-IP pg/mL | 12.35 ± 1.47 | 117.40 ± 62.70 | 0.01 | 0.48 | 15.13 ± 1.50 | 16.90 ± 1.60 | 0.14 | 0.002 |
LPO μM | 2.68 ± 0.28 | 12.60 ± 5.80 | 0.50 | 0.56 | 2.70 ± 0.30 | 2.60 ± 0.30 | 0.26 | 0.11 |
Antioxidant | ||||||||
TAC mM trolox | 429.42 ± 61.50 | 909.30 ± 78.60 | 0.001 | 0.03 | 294.40 ± 24.10 | 337.80 ± 17.10 | 0.19 | <0.001 |
Proinflammatory cytokines | ||||||||
IL-6 pg/mL | 448.34 ± 28.00 | 1342.30 ± 188.90 | 0.007 | 0.42 | 703.50 ± 162.40 | 855.90 ± 327.90 | 0.31 | 0.003 |
TNF-α pg/mL | 160.30 ± 12.70 | 120.80 ± 30.90 | 0.06 | 0.36 | 190.40 ± 17.90 | 164.40 ± 34.22 | 0.18 | 0.001 |
TAC: total antioxidant capacity. ŦHealthy control (HC) versus ascites Mann–Whitney U test. ¥HC versus baseline plasma Mann–Whitney U test. ¤Baseline–final Wilcoxon test. §Baseline plasma versus ascites Mann–Whitney U test.